X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (213) 213
life sciences & biomedicine (212) 212
humans (182) 182
diabetes (144) 144
female (120) 120
male (119) 119
middle aged (119) 119
type 2 diabetes (113) 113
endocrinology & metabolism (108) 108
aged (93) 93
diabetes mellitus, type 2 - drug therapy (87) 87
risk factors (87) 87
hypoglycemic agents - therapeutic use (71) 71
abridged index medicus (69) 69
cardiovascular disease (60) 60
diabetes mellitus (55) 55
cardiovascular diseases (53) 53
general & internal medicine (52) 52
medicine, general & internal (52) 52
diabetes mellitus, type 2 - blood (48) 48
diabetes mellitus, type 2 - complications (48) 48
care and treatment (46) 46
research (44) 44
adult (43) 43
blood pressure (41) 41
cardiovascular system & cardiology (40) 40
clinical trials (40) 40
glucose (40) 40
follow-up studies (39) 39
treatment outcome (39) 39
double-blind method (38) 38
insulin (38) 38
mortality (36) 36
cardiac & cardiovascular systems (35) 35
drug therapy (33) 33
patient outcomes (33) 33
cardiovascular diseases - prevention & control (29) 29
health risk assessment (29) 29
prospective studies (28) 28
blood glucose - metabolism (27) 27
analysis (26) 26
studies (26) 26
medical research (25) 25
hypoglycemic agents - adverse effects (24) 24
patients (24) 24
cardiovascular diseases - epidemiology (23) 23
metformin - therapeutic use (23) 23
myocardial infarction (23) 23
proportional hazards models (23) 23
research design (23) 23
body mass index (22) 22
diagnosis (22) 22
health aspects (22) 22
heart diseases (22) 22
incidence (22) 22
complications and side effects (21) 21
diabetes mellitus, type 2 - epidemiology (21) 21
glycated hemoglobin a - metabolism (21) 21
hyperglycemia (21) 21
heart failure (20) 20
hypoglycemic agents (20) 20
stroke (20) 20
diabetes therapy (19) 19
heart attacks (19) 19
cardiovascular diseases - mortality (18) 18
diabetes mellitus, type 2 - physiopathology (18) 18
glycated hemoglobin a - analysis (18) 18
hypertension (18) 18
metformin (18) 18
united kingdom (18) 18
blood glucose - drug effects (17) 17
hypoglycemic agents - administration & dosage (17) 17
type 2 diabetes mellitus (17) 17
united kingdom - epidemiology (17) 17
dextrose (16) 16
diabetic angiopathies - epidemiology (16) 16
dosage and administration (16) 16
drug therapy, combination (16) 16
heart attack (16) 16
insulin - therapeutic use (16) 16
randomized controlled trials as topic (16) 16
blood glucose (15) 15
cholesterol (15) 15
diabetes complications (15) 15
diabetes mellitus, type 2 - mortality (15) 15
evaluation (15) 15
fasting (15) 15
risk assessment (15) 15
sitagliptin (15) 15
sitagliptin phosphate - therapeutic use (15) 15
time factors (15) 15
cerebral infarction (14) 14
clinical medicine (14) 14
prevention (14) 14
blood glucose - analysis (13) 13
cardiovascular diseases - complications (13) 13
death (13) 13
diabetes mellitus, type 2 - diagnosis (13) 13
diabetic angiopathies - prevention & control (13) 13
hypoglycemia (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes Care, ISSN 0149-5992, 01/2009, Volume 32, Issue 1, pp. 193 - 203
.... Buse , MD, PHD 2 , Mayer B. Davidson , MD 3 , Ele Ferrannini , MD 4 , Rury R. Holman , FRCP 5 , Robert Sherwin , MD 6 and Bernard Zinman , MD 7 1 Diabetes Center... 
Journal Article
American Heart Journal, ISSN 0002-8703, 2013, Volume 166, Issue 6, pp. 983 - 989.e7
Sitagliptin, an oral dipeptidyl peptidase-4 inhibitor, lowers blood glucose when administered as monotherapy or in combination with other antihyperglycemic... 
Cardiovascular | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Metformin - therapeutic use | Humans | Middle Aged | Stroke - complications | Male | Pyrazines - therapeutic use | Cardiovascular Diseases - complications | Thiazolidinediones - therapeutic use | Glycated Hemoglobin A | Aged, 80 and over | Cardiovascular Diseases - blood | Cardiovascular Diseases - mortality | Female | Sitagliptin Phosphate | Drug Therapy, Combination | Diabetes Mellitus, Type 2 - complications | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Double-Blind Method | Sulfonylurea Compounds - therapeutic use | Treatment Outcome | Myocardial Infarction - complications | Diabetes Mellitus, Type 2 - blood | Angina, Unstable - complications | Aged | Diabetes Mellitus, Type 2 - drug therapy | Research Design | Insulin - therapeutic use | Type 2 diabetes | Evaluation | Glucose metabolism | Care and treatment | Blood sugar | Patient outcomes | Clinical trials | Hemoglobin | Hypoglycemic agents | Cardiovascular diseases | Heart attack | Diabetes therapy | Mortality | Cardiovascular disease | FDA approval | Glucose | Abdomen | Ultrasonic imaging | Algorithms | Cysts | Rodents | Insulin resistance | Diabetes | Pancreas | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 383, Issue 9922, pp. 1059 - 1066
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
Medicine(all) | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2016, Volume 30, Issue 3, pp. 329 - 329
Journal Article
Journal Article